Cryoport, Inc.: CADIAN CAPITAL MANAGEMENT, LP amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Cadian Capital Management amended its Schedule 13G filing on Cryoport, Inc., updating its disclosed stake with the SEC under accession number 0001011438-26-000723. The filing reflects a change in the investment firm's reported position in the life-sciences supply-chain company. The amendment signals a shift in Cadian's holdings, which matters to investors tracking institutional ownership in Cryoport. The filing did not disclose the size or direction of the change in the headline. What to watch next is the specific share count and percentage of the class Cadian now reports, along with any further 13G or 13D activity from the firm.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
CADIAN CAPITAL MANAGEMENT, LP, Cryoport, Inc.